• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

InterMune Inc

+ Add to Watchlist


33.497 EUR 0.038 0.11%

As of 09:54:35 ET on 07/29/2014.

Snapshot for InterMune Inc (IUX)

Open: 32.520 Day's Range: 32.520 - 33.510 Volume: 178
Previous Close: 33.535 52wk Range: 8.195 - 35.262 1-Yr Rtn: +204.19%

Stock Chart for IUX

No chart data available.
  • IUX:GR 33.497
  • 1D
  • 1M
  • 1Y
Interactive IUX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IUX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.3100
Est. PEG Ratio -
Market Cap (M EUR) 3,312.29
Shares Outstanding (M) 98.88
30 Day Average Volume 759
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IUX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IUX

InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.

Daniel G Welch "Dan"Chairman/President/CEOJohn HodgmanExec VP/CFO
Sean P NolanExec VP/Chief Business OfficerGiacomo Di NepiExec VP/Managing Dir:Europe
More Company Profile & Key Executives for IUX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil